 The company has operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada.Class B shares of its stock are listed on the NASDAQ OMX Nordic exchange.In 1925 the brothers Harald and Thorvald Pedersen founded Novo Terapeutisk Laboratorium and Nordisk Insulinlaboratorium with the aim to produce insulin.